RECRUITING

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the autonomous AI system in detecting diabetic retinopathy from retinal images of youth with diabetes.

Official Title

Implementing Digital Retinal Exams Into Comprehensive Pediatric Diabetes Care

Quick Facts

Study Start:2022-07-11
Study Completion:2026-03-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05463289

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of Type 1 diabetes for ≥3 years, and age 11 or in puberty
  2. * Diagnosis of Type 2 diabetes
  3. * Patients with Type 1 or Type 2 diabetes,
  4. * 8-21 years of age with known diabetic retinopathy (true positives).
  5. * No time limit on last diabetic eye exam.
  1. * Known diabetic eye exam in the last 12 months

Contacts and Locations

Study Contact

Risa M Wolf, MD
CONTACT
4109556463
RWolf@jhu.edu
Alvin Liu, MD
CONTACT
tliu25@jhmi.edu

Principal Investigator

Risa M Wolf, MD
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Johns Hopkins Pediatric Diabetes Center
Baltimore, Maryland, 21287
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Risa M Wolf, MD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-11
Study Completion Date2026-03-30

Study Record Updates

Study Start Date2022-07-11
Study Completion Date2026-03-30

Terms related to this study

Keywords Provided by Researchers

  • Diabetic Retinopathy

Additional Relevant MeSH Terms

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Cystic Fibrosis-related Diabetes